ONCASPAR 3750U/ml (Pegaspargase Vials) 3750U/ml

ONCASPAR 3750U/ml is a sterile injectable solution containing pegaspargase, an enzyme therapy used in certain cancer treatments. This vial form is stored at 2–8°C and supports chemotherapy regimens. Ideal for patients requiring asparaginase-based protocols.

Strength

3750U/ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Servier Laboratories Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pegaspargase is used as part of combination chemotherapy for acute lymphoblastic leukemia (ALL) and other hematologic cancers. It works by reducing asparagine levels in cancer cells, limiting their growth. This medication is typically administered under medical supervision in clinical settings.

Side Effects

ONCASPAR may cause common effects such as nausea, fatigue, or changes in liver enzyme levels. Some patients experience allergic reactions or infusion-related symptoms. These effects vary by individual and are monitored during treatment.

Precautions & Warnings

Store ONCASPAR 3750U/ml vials refrigerated between 2–8°C and protect from light. Do not freeze or shake vigorously. Use only as directed by a healthcare professional. Discard any unused portion after opening. Keep out of reach of children.

Avoid Interactions

Pegaspargase may interact with other chemotherapy drugs, anticoagulants, or medications affecting liver enzymes. Alcohol and certain supplements could influence its effects. Always inform your doctor about all medications and supplements in use before starting this therapy.

Frequently Asked Questions

Pegaspargase is primarily used to treat acute lymphoblastic leukemia as part of chemotherapy regimens.

It is administered by injection, typically in a clinical setting under medical supervision.

No, it must be refrigerated between 2–8°C and protected from light.

Common effects may include nausea, fatigue, or changes in liver enzymes.

It is an enzyme therapy used alongside chemotherapy for certain cancers.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.